162 related articles for article (PubMed ID: 26614587)
1. HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion.
Lion J; Taflin C; Cross AR; Robledo-Sarmiento M; Mariotto E; Savenay A; Carmagnat M; Suberbielle C; Charron D; Haziot A; Glotz D; Mooney N
Am J Transplant; 2016 May; 16(5):1408-20. PubMed ID: 26614587
[TBL] [Abstract][Full Text] [Related]
2. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions.
Taflin C; Favier B; Baudhuin J; Savenay A; Hemon P; Bensussan A; Charron D; Glotz D; Mooney N
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2891-6. PubMed ID: 21282653
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3
Cross AR; Lion J; Poussin K; Assayag M; Taupin JL; Glotz D; Mooney N
Kidney Int; 2019 Sep; 96(3):689-698. PubMed ID: 31307777
[TBL] [Abstract][Full Text] [Related]
4. Inflammation Determines the Capacity of Allogenic Endothelial Cells to Regulate Human Treg Expansion.
Cross AR; Lion J; Poussin K; Glotz D; Mooney N
Front Immunol; 2021; 12():666531. PubMed ID: 34305898
[TBL] [Abstract][Full Text] [Related]
5. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells.
Waldman WJ; Knight DA; Adams PW; Orosz CG; Sedmak DD
Transplantation; 1993 Dec; 56(6):1504-12. PubMed ID: 7904091
[TBL] [Abstract][Full Text] [Related]
6. Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.
Lion J; Maitre ML; de Truchis C; Taupin JL; Poussin K; Haziot A; Chong E; Glotz D; Mooney N
Clin Transplant; 2023 Mar; 37(3):e14851. PubMed ID: 36495142
[TBL] [Abstract][Full Text] [Related]
7. Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.
Lion J; Maitre ML; de Truchis C; Taupin JL; Poussin K; Haziot A; Chong E; Glotz D; Mooney N
Clin Transplant; 2022 Dec; 36(12):e14815. PubMed ID: 36114597
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin.
Lion J; Burbach M; Cross A; Poussin K; Taflin C; Kaveri S; Haziot A; Glotz D; Mooney N
Front Immunol; 2017; 8():1761. PubMed ID: 29312302
[TBL] [Abstract][Full Text] [Related]
9. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
10. The suppressive effect on CD4 T cell alloresponse against endothelial HLA-DR via PD-L1 induced by anti-A/B ligation.
Iwasaki K; Hamana H; Kishi H; Yamamoto T; Hiramitsu T; Okad M; Tomosugi T; Takeda A; Narumi S; Watarai Y; Miwa Y; Okumura M; Matsuoka Y; Horimi K; Muraguchi A; Kobayash T
Clin Exp Immunol; 2020 Nov; 202(2):249-261. PubMed ID: 32578199
[TBL] [Abstract][Full Text] [Related]
11. HLA class II antibody activation of endothelial cells induces M2 macrophage differentiation in peripheral blood.
Guo Y; Zheng B; Tian P; Zheng J; Li Y; Ding X; Xue W; Ding C
Clin Exp Nephrol; 2023 Apr; 27(4):309-320. PubMed ID: 36611129
[TBL] [Abstract][Full Text] [Related]
12. Human Endothelial Cells Modulate CD4
Lim WC; Olding M; Healy E; Millar TM
Front Immunol; 2018; 9():565. PubMed ID: 29628925
[TBL] [Abstract][Full Text] [Related]
13. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
[TBL] [Abstract][Full Text] [Related]
14. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms.
Watson CA; Petzelbauer P; Zhou J; Pardi R; Bender JR
J Immunol; 1995 Apr; 154(7):3222-33. PubMed ID: 7897208
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies.
Le Bas-Bernardet S; Coupel S; Chauveau A; Soulillou JP; Charreau B
Transplantation; 2004 Dec; 78(12):1729-39. PubMed ID: 15614145
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells.
Fogal B; Yi T; Wang C; Rao DA; Lebastchi A; Kulkarni S; Tellides G; Pober JS
J Immunol; 2011 Dec; 187(12):6268-80. PubMed ID: 22084439
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition.
Iwasaki K; Miwa Y; Uchida K; Kodera Y; Kobayashi T
Transpl Immunol; 2017 Feb; 40():22-30. PubMed ID: 28017877
[TBL] [Abstract][Full Text] [Related]
19. Reviews on mysterious vascular endothelial cells in renal allografts.
Yamaguchi Y
Clin Transplant; 2012 Jul; 26 Suppl 24():13-9. PubMed ID: 22747470
[TBL] [Abstract][Full Text] [Related]
20. Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.
Gajardo T; Morales RA; Campos-Mora M; Campos-Acuña J; Pino-Lagos K
Immunology; 2015 Sep; 146(1):81-8. PubMed ID: 25988395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
